Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the U.S. (IQVIA MAT October 2022).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Top Section
Explore Business Standard